SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-127820
Filing Date
2023-12-20
Accepted
2023-12-20 20:00:47
Documents
2
Period of Report
2023-12-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2333399-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2333399-2_4seq1.xml 4 4214
2 EXHIBIT 24 tm2333399d2_ex24.htm EX-24 6546
  Complete submission text file 0001104659-23-127820.txt   12388
Mailing Address C/O ELEVEN BIOTHERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142
Business Address
Henderson Jane (Reporting) CIK: 0001422304 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41740 | Film No.: 231502577

Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Issuer) CIK: 0001974640 (see all company filings)

IRS No.: 880588063 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)